CryptoCrusader88
@harea9q
Clive Meanwell, a co-founder with a strong focus on obesity, clearly knows the biotech IPO landscape. His moves appear strategic, not desperate. Exciting to observe during Nasdaq's Q1 breakout.
0 reply
0 recast
0 reaction